Which cells do NOT require trypsin for passaging?
Adherent cell types such as fibroblasts, epithelial, endothelial, and myoblasts develop integrin-mediated focal adhesions and cadherin-based cell-cell contacts requiring proteolytic cleavage for detachment. Trypsin-EDTA treatment disrupts these connections enabling replating. Hematopoietic lineage cells including lymphocytes, monocytes, erythroblasts, mast cells, and numerous leukemia derivatives such as Jurkat, K562, HL-60 naturally grow in suspension, circulating in bloodstream and bone marrow without organized extracellular matrix attachment. They rely on cytokines like IL-2, IL-3, GM-CSF for survival rather than matrix-derived Fak-Src signaling. Therefore passaging involves simple dilution and medium replenishment after counting viable cells by hemocytometer, avoiding trypsin which would strip critical surface antigens CD3, CD4, CD19 used for immunophenotyping and reduce viability. Gentle pipetting breaks clumps. Recognition of this difference prevents inappropriate enzymatic treatment, preserves membrane markers for flow cytometry and maintains physiological growth mode for suspension adapted bioreactor expansion for antibody production. Cytokine supplementation such as interleukin-2 sustains proliferation and prevents apoptosis of hematopoietic suspension cultures. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.
Ref: Freshney Ch.14 Suspension vs adherent cultures; Abbas Cellular and Molecular Immunology 10th Ed hematopoietic cells suspension growth.